EX-99.SECTION 19(A) 4 a17-24477_1ex99dsection19a.htm EX-99.SECTION 19(A)

Exhibit 99.Section 19(a)

 

EXHIBIT 4: SECTION 19(a) NOTICE TO FUND’S SHAREHOLDERS

 

TEKLA LIFE SCIENCES INVESTORS

 

Notification of Sources of Distribution

 

Distribution Paid Date: June 30, 2017

 

Distribution Amount Per Common Share:  $0.41

 

The following table sets forth the estimated amounts of the current distribution, paid June 30, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital or other capital source. All amounts are expressed per common share.

 

 

 

 

 

 

 

 

 

Percentage

 

 

 

 

 

Percentage

 

 

 

Breakdown of the

 

 

 

 

 

Breakdown

 

Total Cumulative

 

Total Cumulative

 

 

 

Current

 

of Current

 

Distributions for the

 

Distributions for the

 

 

 

Distribution

 

Distribution

 

Fiscal Year to Date(1)

 

Fiscal Year to Date(1)

 

Net Investment Income

 

$

0.0000

 

0

%

$

0.0000

 

0

%

Net Realized ST Cap Gains

 

$

0.0000

 

0

%

$

0.0000

 

0

%

Net Realized LT Cap Gains

 

$

0.4100

 

100

%

$

1.1700

 

100

%

Return of Capital or Other Capital Source

 

$

0.0000

 

0

%

$

0.0000

 

0

%

TOTAL (per common share):

 

$

0.4100

 

100

%

$

1.1700

 

100

%

 

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

 

Average annual total return at NAV for the period from May 31, 2012 through May 31, 2017

 

16.06

%

Annualized current distribution rate expressed as a percentage of NAV as of May 31, 2017

 

8.41

%

Cumulative total return at NAV for the fiscal year, through May 31, 2017(2)

 

3.85

%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of May 31, 2017(1)

 

6.00

%

 

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution plan.

 

The composition of this and subsequent distribution may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $169,921,052 of which $134,750,869 represents net unrealized appreciation of portfolio securities.

 

The amounts and sources of distributions reported in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

 

(1)The Fund’s current fiscal year began on October 1, 2016.

(2)Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2016 through May 31, 2017.

 

Tekla Life Sciences Investors

CUSIP: 87911K100

www.teklacap.com

 

Tekla Capital Management LLC
100 Federal Street, 19th Floor
Boston, Massachusetts 02110

 

617-772-8500
Fax: 617-772-8577

 


 

TEKLA LIFE SCIENCES INVESTORS

 

Notification of Sources of Distribution

 

Distribution Paid Date:  September 29, 2017

 

Distribution Amount Per Common Share:  $0.42

 

The following table sets forth the estimated amounts of the current distribution, paid September 29, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital or other capital source. All amounts are expressed per common share.

 

 

 

 

 

 

 

 

 

Percentage

 

 

 

 

 

Percentage

 

 

 

Breakdown of the

 

 

 

 

 

Breakdown

 

Total Cumulative

 

Total Cumulative

 

 

 

Current

 

of Current

 

Distributions for the

 

Distributions for the

 

 

 

Distribution

 

Distribution

 

Fiscal Year to Date(1)

 

Fiscal Year to Date(1)

 

Net Investment Income

 

$

0.0000

 

0

%

$

0.0000

 

0

%

Net Realized ST Cap Gains

 

$

0.0120

 

3

%

$

0.0120

 

1

%

Net Realized LT Cap Gains

 

$

0.4080

 

97

%

$

1.5780

 

99

%

Return of Capital or Other Capital Source

 

$

0.0000

 

0

%

$

0.0000

 

0

%

TOTAL (per common share):

 

$

0.4200

 

100

%

$

1.5900

 

100

%

 

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

 

Average annual total return at NAV for the period from July 31, 2012 through July 31, 2017

 

17.09

%

Annualized current distribution rate expressed as a percentage of NAV as of July 31, 2017

 

7.84

%

Cumulative total return at NAV for the fiscal year, through July 31, 2017(2)

 

13.86

%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of July 31, 2017(1)

 

7.42

%

 

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution plan.

 

The composition of this and subsequent distribution may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $180,845,130, of which $135,884,800 represents net unrealized appreciation of portfolio securities.

 

The amounts and sources of distributions reported in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

 

(1)The Fund’s current fiscal year began on October 1, 2016.

(2)Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2016 through July 31, 2017.

 

Tekla Life Sciences Investors 
CUSIP: 87911K100
www.teklacap.com

 

Tekla Capital Management LLC
100 Federal Street, 19th Floor
Boston, Massachusetts 02110

 

617-772-8500
Fax: 617-772-8577